"Drug Utilization Review" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.
|Drug Utilization Review
- Drug Utilization Review
- Evaluation, Drug Utilization
- Drug-Use Review
- Drug Use Review
- Drug-Use Reviews
- Reviews, Drug-Use
- Review, Drug Utilization
- Drug Utilization Reviews
- Reviews, Drug Utilization
- Utilization Reviews, Drug
- Utilization Review, Drug
- Drug Utilization Evaluation
- Drug Utilization Evaluations
- Evaluations, Drug Utilization
- Utilization Evaluation, Drug
- Utilization Evaluations, Drug
- Review, Drug-Use
- Review, Drug Use
Below are MeSH descriptors whose meaning is more general than "Drug Utilization Review".
Below are MeSH descriptors whose meaning is more specific than "Drug Utilization Review".
This graph shows the total number of publications written about "Drug Utilization Review" by people in this website by year, and whether "Drug Utilization Review" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Drug Utilization Review" by people in Profiles.
Maclagan LC, Maxwell CJ, Harris DA, Campitelli MA, Diong C, Lapane KL, Hogan DB, Rochon P, Herrmann N, Bronskill SE. Sex Differences in Antipsychotic and Benzodiazepine Prescribing Patterns: A Cohort Study of Newly Admitted Nursing Home Residents with Dementia in Ontario, Canada. Drugs Aging. 2020 11; 37(11):817-827.
Greenwood BC. Introduction: Pharmacy Reimbursement. J Manag Care Spec Pharm. 2020 Jun; 26(6):702.
Illoh OA, Toh S, Andrade SE, Hampp C, Sahin L, Gelperin K, Taylor L, Bird ST. Utilization of drugs with pregnancy exposure registries during pregnancy. Pharmacoepidemiol Drug Saf. 2018 06; 27(6):604-611.
Hydery T, Price MK, Greenwood BC, Takeshita M, Kunte PS, Mauro RP, Lenz K, Jeffrey PL. Evaluation of Progesterone Utilization and Birth Outcomes in a State Medicaid Plan. Pharmacotherapy. 2017 Oct; 37(10):1328-1334.
Hunnicutt JN, Ulbricht CM, Tjia J, Lapane KL. Pain and pharmacologic pain management in long-stay nursing home residents. Pain. 2017 06; 158(6):1091-1099.
Herzig SJ, Rothberg MB, Guess JR, Gurwitz JH, Marcantonio ER. Antipsychotic medication utilization in nonpsychiatric hospitalizations. J Hosp Med. 2016 08; 11(8):543-9.
Herzig SJ, Rothberg MB, Guess JR, Stevens JP, Marshall J, Gurwitz JH, Marcantonio ER. Antipsychotic Use in Hospitalized Adults: Rates, Indications, and Predictors. J Am Geriatr Soc. 2016 Feb; 64(2):299-305.
Lapane KL, Hunnicutt JN, Tjia J. Appropriateness of Psychopharmaco-logical Medication. J Am Geriatr Soc. 2015 Apr; 63(4):832-4.
Garcia MM, Angelini MC, Thomas T, Lenz K, Jeffrey P. Implementation of an opioid management initiative by a state Medicaid program. J Manag Care Spec Pharm. 2014 May; 20(5):447-54.
Johnson KE, Beaton SJ, Andrade SE, Cheetham TC, Scott PE, Hammad TA, Dashevsky I, Cooper WO, Davis RL, Pawloski PA, Raebel MA, Smith DH, Toh S, Li DK, Haffenreffer K, Dublin S. Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes. Pharmacoepidemiol Drug Saf. 2013 Jul; 22(7):776-82.